Skip to main content

Reporter Sept 13 2013

Nobel laureate Beutler to speak at VU Sept. 23

Sep. 12, 2013—Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall.

Read more


Breakfast free for children Sept. 17

Sep. 12, 2013—In observance of No Kid Hungry’s Hunger Awareness month in September, The Courtyard Café will be giving away breakfast to children under 12 on Tuesday, Sept. 17.

Read more


School of Nursing receives renewal of HRSA grants

Sep. 12, 2013—Vanderbilt University School of Nursing has received a $427,499 award from the Nurse Faculty Loan Program (NFLP) for 2013-14, marking the 10th consecutive year that VUSN has received the grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA).

Read more


Embolism not about to change young singer’s tune

Sep. 12, 2013—As a member of the Tune Town Show Chorus, 20-year-old Kyla Hallums was used to belting out songs and thought it strange when she became short of breath on Sept. 1.

Read more


Options to treat childhood C. diff. infection studied

Sep. 12, 2013—After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections.

Read more


MRI used as new tool in predicting lymphedema risk

Sep. 12, 2013—A new Vanderbilt study is the first to use magnetic resonance imaging (MRI) to noninvasively measure lymphatic flow.

Read more


Program takes new approach to pain management

Sep. 12, 2013—Patients with chronic pain who are covered by the Vanderbilt Employee Health Care Plan or workers’ compensation system can now enroll in an innovative rehabilitation program that could dramatically change how chronic pain is treated.

Read more


‘Proofreader’ key to coronavirus growth

Sep. 12, 2013—A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more